Skip to content

Effect of Auricular Stimulation on Locomotion in Patients With Parkinson's Disease

Effect of Auricular Stimulation on Locomotion in Patients With Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03907007
Enrollment
10
Registered
2019-04-08
Start date
2017-12-01
Completion date
2018-05-01
Last updated
2020-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson Disease

Keywords

Neurostimulator

Brief summary

The effect of auricular stimulation on the locomotion capability in patients with Parkinson's Disease was investigated.

Detailed description

Effect of the auricular stimulation as a supplementary and alternative usage to Levodopa was investigated in this study. Clinical data were collected through motion capture system while the participants performed the clinical task asked by the investigators.

Interventions

Stimulation and medication at the same instant

Sponsors

Inventram
Lead SponsorINDUSTRY
Koç University
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Diagnosis of Parkinson's Disease * H&Y Stage \>= 1 * Existing bradykinesia symptoms * Existence of one of the symptoms below * Resting Tremor * Rigidity * Walking disorder

Exclusion criteria

* Cardiac Pacemaker * Psychiatric diagnosis * Irregular heart/respiration rate * Pregnancy * Alcohol consumption * Cardiovascular disease history * Wearing an electro-active prosthesis * Brain surgery history * Ongoing TENS/PENS therapy

Design outcomes

Primary

MeasureTime frameDescription
Stride length [m]Time Frame: BaselineMeasurement through motion capture system
Stride velocity [m/s]Time Frame: BaselineMeasurement through motion capture system
Turning Velocity [deg/s]Time Frame: BaselineMeasurement through motion capture system
Double Support Percentage during walking [%]Time Frame: Baseline, 20 minutes, 40 minutes, 60 minutesMeasurement through motion capture system
Swing Phase Percentage during walking [%]Time Frame: BaselineMeasurement through motion capture system
Stance Phase Percentage during walking [%]Time Frame: Baseline, 20 minutes, 40 minutes, 60 minutesMeasurement through motion capture system

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 17, 2026